Profusa Common Stock Stock Today
| PFSA Stock | 0.1 0 2.10% |
PerformanceWeakest
| Odds Of DistressRisky
|
Profusa Common is trading at 0.0979 as of the 8th of January 2026, a 2.1 percent decrease since the beginning of the trading day. The stock's open price was 0.1. Profusa Common has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 9th of December 2025 and ending today, the 8th of January 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 11th of July 2025 | Category Healthcare | Classification Health Care |
Profusa Common is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 41.76 M outstanding shares of which 2.25 M shares are at this time shorted by private and institutional investors with about 0.57 trading days to cover. More on Profusa Common Stock
Moving together with Profusa Stock
Moving against Profusa Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Profusa Stock Highlights
| CEO Chairman | Ben Hwang | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Technology, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsProfusa Common can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Profusa Common's financial leverage. It provides some insight into what part of Profusa Common's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Profusa Common Stock (PFSA) is traded on NASDAQ Exchange in USA and employs 6 people. Profusa Common is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.85 M. Profusa Common Stock conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 41.76 M outstanding shares of which 2.25 M shares are at this time shorted by private and institutional investors with about 0.57 trading days to cover.
Profusa Common generates negative cash flow from operations
Check Profusa Common Probability Of Bankruptcy
Ownership AllocationProfusa Common owns a total of 41.76 Million outstanding shares. Profusa Common has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Profusa Ownership Details
Profusa Common Historical Income Statement
Profusa Stock Against Markets
Profusa Common Corporate Management
| Fred Knechtel | Chief Officer | Profile | |
| David Icke | Head Business | Profile | |
| Sean Givens | Head Business | Profile | |
| Phil Constantinou | Head Science | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profusa Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profusa Common. If investors know Profusa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profusa Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Profusa Common Stock is measured differently than its book value, which is the value of Profusa that is recorded on the company's balance sheet. Investors also form their own opinion of Profusa Common's value that differs from its market value or its book value, called intrinsic value, which is Profusa Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profusa Common's market value can be influenced by many factors that don't directly affect Profusa Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profusa Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profusa Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profusa Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.